Axxia Pharmaceuticals, LLC — Form D

Axxia Pharmaceuticals, LLC of BEL AIR, MD, a company, filed a Form D exempt-offering notice with the SEC on 2013-02-14. The offering totals $300K. Industry: Pharmaceuticals.

Offering

Filed: 2013-02-14
Form: D
Accession: 0001514545-13-000001
Industry: Pharmaceuticals
Exemptions: 06
Total offering: $300K
Remaining: $300K
Minimum investment: $1K
Security types: equity
Revenue range: No Revenues
SEC file number: 021-191838

Issuer

Name: Axxia Pharmaceuticals, LLC
CIK: 0001514545
Entity type: Limited Liability Company
Jurisdiction: MARYLAND
Address: 2614 WEST MEDICAL HALL ROAD, BEL AIR, MD, 21015
Phone: (610) 255-4474

Officers, directors & promoters (18)

Name	Role	Location
Thomas E Byrne	Director	Bel Air, MD
Wally D Grimm	Director	Bel Air, MD
Stuart W Grossman	Director	Bel Air, MD
Sally W MacConnell	Director	Bel Air, MD
Wally Phillip Grimm	Director	Bel Air, MD
Bernard Phillip Rudnick	Director	Bel Air, MD
Bernard Phillip Rudnick	Executive Officer	Bel Air, MD
Sally Phillip MacConnell	Director	Bel Air, MD
D. Phillip Cox	Director	Bel Air, MD
D. Phillip Cox	Executive Officer	Bel Air, MD
Stuart Phillip Grossman	Director	Bel Air, MD
Wayne Pollock	Director	Bel Air, MD
Wayne Pollock	Executive Officer	Bel Air, MD
David Phillip Wheatley	Director	Bel Air, MD
Julio D Sy, Jr.	Director	Bel Air, MD
June E Sy	Director	Bel Air, MD
Stuart A Grossman	Director	Bel Air, MD
Jun E Sy	Director	Bel Air, MD

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2017-02-02	D	$3.0M	—
2012-03-12	D	$800K	$300K
2011-09-23	D	$350K	—
2011-04-01	D	$100K	$100K
2011-03-04	D	$150K	$150K

More